[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
:: Volume 8, Issue 31 (7-2018) ::
NCMBJ 2018, 8(31): 86-94 Back to browse issues page
The effect of contrast agents and Tc-99m radionuclide simultaneously to increase the dose in cancer therapy
Hadis Alizadeh , Seyed Pezhman Shirmardi , Rasoul Khodabakhsh , Mostafa Erfani , Reza Bagheri
Nuclear Science and Technology Research Institute (NSTRI), Tehran, Iran, Postal code: 14155-1339.
Abstract:   (929 Views)
Aim and Background:
One of the methods of cancer treatment is the use of beta and alpha emitter radionuclides such as iodine-131 and radium -223. Gamma-radionuclides are not usually used for treatment due to high gamma-ray penetration and lower absorption in the tissue, and they are mostly diagnostic. In this study, a new method is proposed in which the feasibility of using 99mTcO-4 as a gamma-emitting radionuclide for the treatment of cancer by adding high-atomic substances such as iodine and gadolinium to increase the surface area of ​​photon absorption in the tissue and Finally, an increase in the absorbed dose of the tumor is investigated.
Material and methods:
Radiopharmaceutical 99mTcO-4 was milked from a 99Mo/99mTc generator, and after injection, the mice were killed at different times and the percentage of injected dose per gram of each member was determined by direct counting of mice data. Then, by transforming the mice results into humans, the dose of internal radiation was calculated. In the next step, by introducing contrast agents (I, Gd) at different concentrations in the target organs, the rate of change in absorbed dose of organs was calculated using the MCNP simulation code.
 MCNP results  show that the absorbed dose has increased in the presence of contrast agents (I, Gd) in the liver and lung, taking into account the human accumulation activity (derived from healthy mice).
Dose enhancement factor was evaluated using contrast agents. The results showed that with increasing concentrations, the dose enhancement factor in the target  region increases in the presence of contrast agent and the dose outside the target position decreases. As a consequence of the increased dose resulting from the presence of contrast agents, the diagnostic radionuclide 99mTc can be used as a radionuclide for treatment in future.
Keywords: 99mTcO-4, Effective Dose, Treatment, Contrasting Agent, MCNPX simulation code, MIRD method
Full-Text [PDF 358 kb]   (203 Downloads)    
Type of Study: Research Article | Subject: Cellular and molecular
Received: 2018/09/5 | Accepted: 2018/09/5 | Published: 2018/09/5
Add your comments about this article
Your username or Email:


XML   Persian Abstract   Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Alizadeh H, Shirmardi S P, Khodabakhsh R, Erfani M, Bagheri R. The effect of contrast agents and Tc-99m radionuclide simultaneously to increase the dose in cancer therapy. NCMBJ. 2018; 8 (31) :86-94
URL: http://ncmbjpiau.ir/article-1-1125-en.html

Volume 8, Issue 31 (7-2018) Back to browse issues page
مجله تازه های بیوتکنولوژی سلولی - مولکولی New Cellular and Molecular Biotechnology Journal
Persian site map - English site map - Created in 0.08 seconds with 32 queries by YEKTAWEB 3844